Our HCV Approach

LiverRight triages/diagnoses/treats HCV (and HBV). Here’s a summary of the highly relevant, recent article titled “Hepatitis C Cure Can Be Assessed 4 Weeks After Treatment” (by Liz Highleyman, 11/11/2025) from HEP Magazine.Important to know: The medication referenced...

AUD and Liver Disease

Alcohol use disorder (AUD) is also prevalent with ~10% of all Americans having active disease. Obviously, the overlap between AUD and all stages of hepatic disease is large; ~30% of all alcohol-associated deaths are due to liver disease, 50% of liver transplants are...

Medications for AUD

Naltrexone and Acamprosate are widely used to treat alcohol use disorder (AUD)– Naltrexone: Associated with a greater cumulative number of days of abstinence, fewer drinks, and less severe craving. Studies have shown it can be safe in patients with cirrhosis,...

AASLD Conference Day 4

Here’s what transpired at the annual AASLD The Liver Meeting® 2025 (Washington DC) for Day #4, 11/10/2025 — Programming highlights Morning sessions included the State-of-the-Art Lecture, major general hepatology updates, and “Meet the Experts” (MTE) format sessions....